Enal Drugs Pvt Ltd., a active private limited company, was established on 27 June 1990 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230TG1990PTC011422. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.27 Cr.
It upholds a compliant status. Employing 132 professional, Its leadership includes Nikhil Teja Reddy Mandha (Director), Achyuth Reddy Manne (Director). Past directors included Suresh Babu Sunkaraneni, Surender Reddy Akavaram, Nikhil Teja Reddy Mandha. It holds ₹0.55 M open charges and ₹39.80 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.D-34 & 35, Phase - I Ida, Jeedimetla, Hyderabad, Telangana, 500055.
U24230TG1990PTC011422
011422
27 June 1990
₹10.00 Cr
₹7.27 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Enal Drugs Pvt Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Teja Reddy Mandha | Director | 01 Feb 2024 | Current |
| Achyuth Reddy Manne | Director | 01 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 28 Mar 2025 | Past |
| Pramod Abcsdd | Additional Director | 10 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 28 Mar 2025 | Past |
| Pramod Abcsdd | Director | 20 Dec 2013 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enal Drugs Pvt Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 7.92% increase. The company also saw a substantial fall in profitability, with a 78.85% decrease in profit. The company's net worth moved up by a moderate rise of 1.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Enal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹553,000.00
₹397,982,190.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2000 | The Hsbc Ltd | ₹0.55 M | Open |
| 03 Jan 2023 | Others | ₹1.04 Cr | Satisfied |
| 01 Sep 2022 | Hdfc Bank Limited | ₹3.41 M | Satisfied |
| 26 Apr 2022 | Hdfc Bank Limited | ₹2.57 M | Satisfied |
| 31 Oct 2020 | Others | ₹1.04 Cr | Satisfied |
Explore comprehensive loan charge details -
Enal Drugs has a workforce of 132 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Enal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enal Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Enal Drugs Pvt Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Enal Drugs Pvt Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Nikhil Teja Reddy Mandha was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
Progress on Achyuth Reddy Manne was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
Progress on A charge registered on 07 Aug 2004 via Charge ID 90123267 with State Bank Of India was fully satisfied on 29 Dec 2023. was documented.
Progress on A charge registered on 01 Sep 2022 via Charge ID 100609660 with Hdfc Bank Limited was fully satisfied on 23 Dec 2023. was documented.
The CIN of Enal Drugs Pvt Ltd. is U24230TG1990PTC011422.
Enal Drugs Pvt Ltd. is headquartered at Plot No.D-34 & 35, Phase - I Ida, Jeedimetla, Hyderabad, Telangana, 500055.
Enal Drugs Pvt Ltd. was incorporated on 27 June 1990.
The current directors of Enal Drugs Pvt Ltd. are
The primary industry of Enal Drugs Pvt Ltd. is Manufacturing.
Enal Drugs Pvt Ltd. is unlisted.
The authorized capital of Enal Drugs Pvt Ltd. is ₹10.00 Cr, and the paid-up capital is ₹7.27 Cr.
The compliance status of Enal Drugs Pvt Ltd. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX